Literature DB >> 19924030

Adenosine A2A receptor-selective stimulation reduces signaling pathways involved in the development of intestine ischemia and reperfusion injury.

Rosanna Di Paola1, Alessia Melani, Emanuela Esposito, Emanuela Mazzon, Irene Paterniti, Placido Bramanti, Felicita Pedata, Salvatore Cuzzocrea.   

Abstract

In the present study, we tested the efficacy of treatment with the selective adenosine A2A receptor agonist 2-[p-(2-carboxyethyl)phenylethylamino]-50-ethylcarboxamidoadenosine (CGS 21680) on ischemia and reperfusion injury of the multivisceral organs. Ischemia and reperfusion injury was induced in mice by clamping both the superior mesenteric artery and the celiac artery for 30 min, followed thereafter by reperfusion. Sixty minutes after reperfusion, animals were killed for histological examination and biochemical studies. Injured vehicle-treated mice developed a significant increase of ileum TNF-alpha levels, myeloperoxidase activity, and marked histological injury and apoptosis. Ischemia and reperfusion injury of the multivisceral organs was also associated with significant mortality. Reperfused ileum sections from injured vehicle-treated mice showed positive staining for P-selectin and intercellular adhesion molecule 1. The intensity and degree of P-selectin and intercellular adhesion molecule 1 were markedly reduced in tissue sections from injured CGS 21680-treated mice. Ischemia and reperfusion-injured mice that have been treated with CGS 21680 showed also a significant reduction of neutrophil infiltration into the intestine, a reduction of apoptosis, and improved histological status of the intestine and survival. Taken together, our results clearly demonstrate that selective activation of adenosine A2A receptors plays an important role in the regulation of ischemia and reperfusion injury and results put forward the hypothesis that selective activation of adenosine A2A receptors may represent a novel and possible strategy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19924030     DOI: 10.1097/SHK.0b013e3181c997dd

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  8 in total

Review 1.  Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences.

Authors:  Brigitte Vollmar; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-11-19       Impact factor: 3.445

Review 2.  Targeting iNKT cells for the treatment of sickle cell disease.

Authors:  Joshua J Field; David G Nathan; Joel Linden
Journal:  Clin Immunol       Date:  2011-03-22       Impact factor: 3.969

Review 3.  Regulation of leukocyte function by adenosine receptors.

Authors:  Joel Linden
Journal:  Adv Pharmacol       Date:  2011

4.  Functional and RNA expression profile of adenosine receptor subtypes in mouse mesenteric arteries.

Authors:  Bunyen Teng; Daniel Fil; Stephen L Tilley; Catherine Ledent; Thomas Krahn; S Jamal Mustafa
Journal:  J Cardiovasc Pharmacol       Date:  2013-01       Impact factor: 3.105

Review 5.  Purinergic signalling in the gastrointestinal tract and related organs in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-12-04       Impact factor: 3.765

6.  A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment.

Authors:  Melanie Mediavilla-Varela; Julio Castro; Alberto Chiappori; David Noyes; Dalia C Hernandez; Bertrand Allard; John Stagg; Scott J Antonia
Journal:  Neoplasia       Date:  2017-06-03       Impact factor: 5.715

7.  Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment.

Authors:  Yuesheng Li; Robert A Figler; Glynis Kolling; Tara C Bracken; Jayson Rieger; Ralph W Stevenson; Joel Linden; Richard L Guerrant; Cirle Alcantara Warren
Journal:  BMC Infect Dis       Date:  2012-12-10       Impact factor: 3.090

Review 8.  Adenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemia.

Authors:  Felicita Pedata; Anna Maria Pugliese; Elisabetta Coppi; Ilaria Dettori; Giovanna Maraula; Lucrezia Cellai; Alessia Melani
Journal:  Mediators Inflamm       Date:  2014-08-05       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.